Update: 07.09.2022
Last week: 34 week 2022 (22.08.2022 - 28.08.2022)
Last full month: July 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 104 552 | 4.6% | 3.7% | -0.2 | 20 649 206 | 3.7% | 3.7% | -0.1 | 8.9% |
| MoM | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| YTD | 6 874 336 | 8.0% | 5.8% | 0 | 1 358 266 558 | 27.3% | 5.5% | 0.3 | 8.6% |
| MAT | 13 779 992 | 31.6% | 6.3% | 1.1 | 2 581 772 702 | 53.6% | 5.9% | 1.3 | 8.8% |
| DEXALGIN | |||||||||
| WoW | 17 854 | -0.7% | 0.4% | 0 | 8 352 509 | -0.6% | 1.1% | 0 | 1.6% |
| MoM | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| YTD | 1 242 614 | 16.3% | 0.7% | 0.1 | 519 090 003 | 27.9% | 2.0% | 0.2 | 3.6% |
| MAT | 2 013 053 | 9.1% | 0.8% | 0 | 814 074 469 | 18.1% | 2.1% | 0.1 | 2.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 57 735 | 0.3% | 46.4% | 0.2 | 30 500 557 | 0.5% | 52.2% | -0.5 | -0.1% |
| MoM | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| YTD | 3 248 350 | -1.4% | 57.4% | -9.2 | 1 643 877 862 | 10.7% | 62.8% | -7.4 | 14.3% |
| MAT | 5 234 445 | 4.0% | 60.0% | -6.1 | 2 583 774 865 | 17.5% | 65.5% | -4.6 | 14.5% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 501 | 0.6% | 34.3% | -0.2 | 15 127 597 | 0.5% | 47.1% | -0.3 | 1.1% |
| MoM | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| YTD | 995 231 | -8.7% | 38.5% | -3.5 | 615 944 555 | -2.6% | 51.8% | -5 | -0.5% |
| MAT | 1 567 978 | -9.9% | 39.1% | -2.3 | 955 390 100 | -1.8% | 52.9% | -2.5 | -4.6% |
| FASTUM | |||||||||
| WoW | 15 111 | 2.7% | 0.9% | 0 | 8 360 575 | 3.6% | 2.2% | 0.1 | -0.1% |
| MoM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| YTD | 751 119 | -17.3% | 1.2% | -0.3 | 383 947 994 | -8.0% | 2.6% | -0.6 | 1.9% |
| MAT | 1 227 313 | -15.5% | 1.3% | -0.3 | 606 650 721 | -7.1% | 2.8% | -0.5 | 1.3% |
| IODOMARIN | |||||||||
| WoW | 61 177 | 5.2% | 22.8% | 0.7 | 11 616 472 | 4.7% | 10.1% | 0.3 | 1.8% |
| MoM | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| YTD | 1 972 400 | 5.8% | 19.0% | -0.1 | 395 859 392 | 12.8% | 8.6% | 0 | 6.1% |
| MAT | 3 274 230 | 23.5% | 20.5% | 2.7 | 637 275 375 | 25.0% | 9.3% | 1 | 7.1% |
| LIOTON | |||||||||
| WoW | 20 516 | -6.4% | 2.0% | -0.1 | 22 218 368 | -6.0% | 4.3% | -0.1 | -2.8% |
| MoM | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| YTD | 949 943 | -19.8% | 2.4% | -0.4 | 966 862 617 | 1.0% | 4.9% | -0.7 | -6.1% |
| MAT | 1 458 456 | -16.1% | 2.5% | -0.3 | 1 411 996 221 | 2.8% | 5.1% | -0.5 | -6.0% |
| MEZYM | |||||||||
| WoW | 212 703 | -2.3% | 19.6% | -0.2 | 32 101 603 | -2.3% | 13.8% | -0.2 | -1.4% |
| MoM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| YTD | 13 313 636 | 11.1% | 28.5% | 1.6 | 2 036 994 263 | 20.5% | 20.4% | 0.3 | 4.8% |
| MAT | 22 090 855 | 17.9% | 30.0% | 2.7 | 3 255 701 657 | 24.2% | 21.8% | 1.1 | 7.2% |
| MIG 400 | |||||||||
| WoW | 141 415 | 0.5% | 2.9% | 0 | 16 843 626 | 0.5% | 2.2% | 0 | 1.6% |
| MoM | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| YTD | 5 821 101 | -6.0% | 3.5% | -0.4 | 683 396 280 | -2.3% | 2.6% | -0.4 | 3.6% |
| MAT | 9 517 978 | 2.5% | 3.6% | 0 | 1 100 477 019 | 6.1% | 2.8% | -0.1 | 2.6% |
| PROSTAMOL | |||||||||
| WoW | 19 184 | -2.8% | 14.9% | -0.2 | 27 206 472 | -2.1% | 15.9% | -0.1 | -1.2% |
| MoM | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| YTD | 1 118 784 | -17.9% | 20.1% | -4.9 | 1 570 795 812 | -7.7% | 21.4% | -5.9 | 2.1% |
| MAT | 1 896 434 | -10.0% | 21.5% | -3 | 2 568 560 699 | -1.4% | 22.9% | -3.9 | 2.6% |
| RESPERO MYRTOL | |||||||||
| WoW | 16 289 | 3.6% | 8.9% | -0.3 | 7 644 231 | 3.1% | 9.0% | -0.3 | 6.8% |
| MoM | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
| YTD | 811 866 | 183.3% | 9.1% | 5.6 | 378 318 195 | 175.0% | 8.8% | 4.9 | 8.9% |
| MAT | 1 272 065 | 125.9% | 8.3% | 4.2 | 585 629 556 | 114.9% | 8.1% | 3.4 | 11.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 874 336 | 8.0% | 5.8% | 0 | 1 358 266 558 | 27.3% | 5.5% | 0.3 | 8.6% |
| DEXALGIN | 1 242 614 | 16.3% | 0.7% | 0.1 | 519 090 003 | 27.9% | 2.0% | 0.2 | 3.6% |
| ESPUMISAN (ADULTS) | 3 248 350 | -1.4% | 57.4% | -9.2 | 1 643 877 862 | 10.7% | 62.8% | -7.4 | 14.3% |
| ESPUMISAN BABY | 995 231 | -8.7% | 38.5% | -3.5 | 615 944 555 | -2.6% | 51.8% | -5 | -0.5% |
| FASTUM | 751 119 | -17.3% | 1.2% | -0.3 | 383 947 994 | -8.0% | 2.6% | -0.6 | 1.9% |
| IODOMARIN | 1 972 400 | 5.8% | 19.0% | -0.1 | 395 859 392 | 12.8% | 8.6% | 0 | 6.1% |
| LIOTON | 949 943 | -19.8% | 2.4% | -0.4 | 966 862 617 | 1.0% | 4.9% | -0.7 | -6.1% |
| MEZYM | 13 313 636 | 11.1% | 28.5% | 1.6 | 2 036 994 263 | 20.5% | 20.4% | 0.3 | 4.8% |
| MIG 400 | 5 821 101 | -6.0% | 3.5% | -0.4 | 683 396 280 | -2.3% | 2.6% | -0.4 | 3.6% |
| PROSTAMOL | 1 118 784 | -17.9% | 20.1% | -4.9 | 1 570 795 812 | -7.7% | 21.4% | -5.9 | 2.1% |
| RESPERO MYRTOL | 811 866 | 183.3% | 9.1% | 5.6 | 378 318 195 | 175.0% | 8.8% | 4.9 | 8.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 13 779 992 | 31.6% | 6.3% | 1.1 | 2 581 772 702 | 53.6% | 5.9% | 1.3 | 8.8% |
| DEXALGIN | 2 013 053 | 9.1% | 0.8% | 0 | 814 074 469 | 18.1% | 2.1% | 0.1 | 2.6% |
| ESPUMISAN (ADULTS) | 5 234 445 | 4.0% | 60.0% | -6.1 | 2 583 774 865 | 17.5% | 65.5% | -4.6 | 14.5% |
| ESPUMISAN BABY | 1 567 978 | -9.9% | 39.1% | -2.3 | 955 390 100 | -1.8% | 52.9% | -2.5 | -4.6% |
| FASTUM | 1 227 313 | -15.5% | 1.3% | -0.3 | 606 650 721 | -7.1% | 2.8% | -0.5 | 1.3% |
| IODOMARIN | 3 274 230 | 23.5% | 20.5% | 2.7 | 637 275 375 | 25.0% | 9.3% | 1 | 7.1% |
| LIOTON | 1 458 456 | -16.1% | 2.5% | -0.3 | 1 411 996 221 | 2.8% | 5.1% | -0.5 | -6.0% |
| MEZYM | 22 090 855 | 17.9% | 30.0% | 2.7 | 3 255 701 657 | 24.2% | 21.8% | 1.1 | 7.2% |
| MIG 400 | 9 517 978 | 2.5% | 3.6% | 0 | 1 100 477 019 | 6.1% | 2.8% | -0.1 | 2.6% |
| PROSTAMOL | 1 896 434 | -10.0% | 21.5% | -3 | 2 568 560 699 | -1.4% | 22.9% | -3.9 | 2.6% |
| RESPERO MYRTOL | 1 272 065 | 125.9% | 8.3% | 4.2 | 585 629 556 | 114.9% | 8.1% | 3.4 | 11.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 104 552 | 4.6% | 3.7% | -0.2 | 20 649 206 | 3.7% | 3.7% | -0.1 | 8.9% |
| DEXALGIN | 17 854 | -0.7% | 0.4% | 0 | 8 352 509 | -0.6% | 1.1% | 0 | 1.6% |
| ESPUMISAN (ADULTS) | 57 735 | 0.3% | 46.4% | 0.2 | 30 500 557 | 0.5% | 52.2% | -0.5 | -0.1% |
| ESPUMISAN BABY | 23 501 | 0.6% | 34.3% | -0.2 | 15 127 597 | 0.5% | 47.1% | -0.3 | 1.1% |
| FASTUM | 15 111 | 2.7% | 0.9% | 0 | 8 360 575 | 3.6% | 2.2% | 0.1 | -0.1% |
| IODOMARIN | 61 177 | 5.2% | 22.8% | 0.7 | 11 616 472 | 4.7% | 10.1% | 0.3 | 1.8% |
| LIOTON | 20 516 | -6.4% | 2.0% | -0.1 | 22 218 368 | -6.0% | 4.3% | -0.1 | -2.8% |
| MEZYM | 212 703 | -2.3% | 19.6% | -0.2 | 32 101 603 | -2.3% | 13.8% | -0.2 | -1.4% |
| MIG 400 | 141 415 | 0.5% | 2.9% | 0 | 16 843 626 | 0.5% | 2.2% | 0 | 1.6% |
| PROSTAMOL | 19 184 | -2.8% | 14.9% | -0.2 | 27 206 472 | -2.1% | 15.9% | -0.1 | -1.2% |
| RESPERO MYRTOL | 16 289 | 3.6% | 8.9% | -0.3 | 7 644 231 | 3.1% | 9.0% | -0.3 | 6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| DEXALGIN | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| ESPUMISAN (ADULTS) | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| ESPUMISAN BABY | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| FASTUM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| IODOMARIN | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| LIOTON | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| MEZYM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| MIG 400 | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| PROSTAMOL | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| RESPERO MYRTOL | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs